These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29558165)

  • 1. Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management.
    Lopez-Campos JL; Centanni S
    COPD; 2018 Apr; 15(2):108-117. PubMed ID: 29558165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.
    Lopez-Campos JL; Bustamante V; Muñoz X; Barreiro E
    COPD; 2014 Sep; 11(5):591-602. PubMed ID: 24914771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The path to personalised medicine in COPD.
    Agusti A
    Thorax; 2014 Sep; 69(9):857-64. PubMed ID: 24781218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging.
    Washko GR; Parraga G
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine and treatable traits in chronic airway diseases - where do we stand?
    Ulrik CS; Vijverberg S; Hanania NA; Diamant Z
    Curr Opin Pulm Med; 2020 Jan; 26(1):33-39. PubMed ID: 31644440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease subpopulations and phenotyping.
    Segal LN; Martinez FJ
    J Allergy Clin Immunol; 2018 Jun; 141(6):1961-1971. PubMed ID: 29884286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD evaluation: back to the future.
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Feb; 46(2):53-5. PubMed ID: 20092931
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction to precision medicine in COPD.
    Leung JM; Obeidat M; Sadatsafavi M; Sin DD
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30679189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatable traits: toward precision medicine of chronic airway diseases.
    Agusti A; Bel E; Thomas M; Vogelmeier C; Brusselle G; Holgate S; Humbert M; Jones P; Gibson PG; Vestbo J; Beasley R; Pavord ID
    Eur Respir J; 2016 Feb; 47(2):410-9. PubMed ID: 26828055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Developing Biomarkers in Precision Medicine for Asthma and COPD].
    Hirai K
    Yakugaku Zasshi; 2023; 143(3):249-255. PubMed ID: 36858558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Subramanian DR; Gupta S; Burggraf D; Vom Silberberg SJ; Heimbeck I; Heiss-Neumann MS; Haeussinger K; Newby C; Hargadon B; Raj V; Singh D; Kolsum U; Hofer TP; Al-Shair K; Luetzen N; Prasse A; Müller-Quernheim J; Benea G; Leprotti S; Boschetto P; Gorecka D; Nowinski A; Oniszh K; Castell WZ; Hagen M; Barta I; Döme B; Strausz J; Greulich T; Vogelmeier C; Koczulla AR; Gut I; Hohlfeld J; Welte T; Lavae-Mokhtari M; Ziegler-Heitbrock L; Brightling C; Parr DG
    Eur Respir J; 2016 Jul; 48(1):92-103. PubMed ID: 27230444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers, the control panel and personalized COPD medicine.
    Agusti A; Gea J; Faner R
    Respirology; 2016 Jan; 21(1):24-33. PubMed ID: 26172306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
    Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
    Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From COPD definitions to COPD phenotypes].
    Burgel PR
    Presse Med; 2014 Dec; 43(12 Pt 1):1337-43. PubMed ID: 25448122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatable traits of chronic airways disease.
    Fingleton J; Hardy J; Beasley R
    Curr Opin Pulm Med; 2018 Jan; 24(1):24-31. PubMed ID: 29049049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.
    Van Tho N; Ogawa E; Trang le TH; Ryujin Y; Kanda R; Nakagawa H; Goto K; Fukunaga K; Higami Y; Seto R; Wada H; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Ann Am Thorac Soc; 2015 Jul; 12(7):988-96. PubMed ID: 25844673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CT-emphysema index/FEV
    Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD: To Be or Not to Be, That is the Question.
    Polverino F; Sam A; Guerra S
    Am J Med; 2019 Nov; 132(11):1271-1278. PubMed ID: 31152719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway inflammation in COPD: progress to precision medicine.
    Brightling C; Greening N
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.